Abiopharma

🔍 VINCIARELLI PATRIZIO (Executive)

Company: VICOR CORP (VICR)

Report Date: 2026-03-25

Detailed Transactions and Holdings:

• Sold 7,350 shares of Common Stock at $181.5698 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 9,027,634.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Sold 8,411 shares of Common Stock at $182.4761 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 9,019,223.00 | transaction_form_type: 4 | Footnotes: F2, F4
• Sold 18,960 shares of Common Stock at $183.7373 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 9,000,263.00 | transaction_form_type: 4 | Footnotes: F2, F5
• Sold 10,000 shares of Common Stock at $185.0 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 8,990,263.00 | transaction_form_type: 4 | Footnotes: F2, F6
• Sold 5,279 shares of Common Stock at $186.0 per share (Direct)
  Date: 2026-03-25 | Code: S | equity_swap_involved: false | shares_owned_after: 8,984,984.00 | transaction_form_type: 4 | Footnotes: F2, F7
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-25 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 171,125.00 | Footnotes: F1

Footnotes:

• F1: These shares are held by the reporting person as Trustee of the Patrizio Vinciarelli Irrevocable Trust U/A Dated 12/21/2012, established for the benefit of the child of the reporting person.
• F2: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 3, 2025.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.0500 to $182.0400. The reporting person undertakes to provide to Vicor Corporation, any security holder of Vicor Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4.
• F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.0500 to $183.0000.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $183.0900 to $184.0000.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.0000 to $185.0000.
• F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.0000 to $186.0000.